March 31, 2021
A California federal judge has delayed a competitor's antitrust suit against Illumina until the DNA-sequencing company's patent infringement claims against the same rival are resolved.
February 23, 2021
Illumina wants a California federal judge to pause a competitor's antitrust suit so the gene-sequencing behemoth can first pursue its patent infringement suit against that same rival.
January 11, 2021
Illumina stifled competition with fraudulently obtained patents and "baseless" infringement litigation, a rival company alleged Monday in a suit filed in California federal court, accusing the gene-sequencing behemoth of maintaining U.S. market dominance by defrauding the patent office and echoing the Federal Trade Commission's proclamation that Illumina is a "monopolist."